Dr. Reddy's Launches Sildenafil Tablets

Dr. Reddy's Laboratories RDY announced today that it has launched Sildenafil Tablets (20 mg), a bioequivalent generic version of REVATIO® (Sildenafil) Tablets in the US market on November 16, 2012, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Sildenafil Tablets. The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health*. Dr. Reddy's Sildenafil Tablets in 20 mg are available in 90 count bottle sizes. Disclaimer This press release includes forward-looking statements, See full press release